|
|
| Research article summary (published 30 Aug 2009): |
Interleukin-1 deficiency in combination with macrophage depletion increases susceptibility to Pseudomonas aeruginosa bacteremia.
Full Abstract
We evaluated the role of IL-1 during Pseudomonas aeruginosa bacteremia by intravenously injecting P. aeruginosa strain D4 into IL-1-deficient and WT mice. The two strains showed equivalent mortality rates. However, when the mice were pretreated with cyclophosphamide, bacteremia-induced mortality was significantly greater in the IL-1-deficient mice than in the WT mice (P < 0.01). We then investigated the role of neutrophils and macrophages in protecting IL-1-deficient mice from bacteremia by administering anti-Gr-1 antibody or liposomes containing dichloromethylene diphosphonate, respectively. After P. aeruginosa inoculation survival was significantly lower in the macrophage-depleted IL-1-deficient mice than in the WT mice. In contrast, neutrophil depletion did not have this effect. Compared to the macrophage-depleted WT mice, the macrophage-depleted IL-1-deficient bacteremic mice had higher bacterial counts in various organs 48 and 72 hr post-infection. They also had lower TNF-alpha, IL-6, and INF-gamma concentrations in their livers during the early phase of sepsis. Thus, IL-1 deficiency becomes disadvantageous during P. aeruginosa bacteremia when it is accompanied by immunosuppression, particularly when macrophage functions are seriously impaired.
Author information
Author/s: Horino, Tetsuya (T); Matsumoto, Tetsuya (T); Ishikawa, Hiroki (H); Kimura, Soichiro (S); Uramatsu, Masashi (M); Tanabe, Masaaki (M); Tateda, Kazuhiro (K); Miyazaki, Shuichi (S); Aramaki, Yukihiko (Y); Iwakura, Yoichiro (Y); Yoshida, Masaki (M); Onodera, Shoichi (S); Yamaguchi, Keizo (K);
Affiliation: Department of Infectious Disease and Infection Control, The Jikei University School of Medicine, 3-19-18 Nishi-Shimbashi, Minato-ku, Tokyo, Japan.
Journal and publication information
Publication Type: Journal Article
Journal: Microbiology and immunology (Microbiol Immunol), published in Japan. (Language: eng)
Reference: 2009-Sep; vol 53 (issue 9) : pp 502-11
Dates: Created 2009/08/25; Completed 2009/10/13;
PMID: 19703244, status: MEDLINE (last retrieved date: 10/13/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Interleukin-1 (0)Related articles
These are the most related articles currently in our database:
- Robbins device in biofilm research.
30 Dec 1998 - Anti-lipopolysaccharide antibody levels in patients with AIDS at the onset of Pseudomonas aeruginosa bacteremia.
30 May 1994 - Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages.
30 Mar 2007 - Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.
30 Oct 1996 - The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin.
29 Nov 1998 - Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies.
13 Aug 2001 - Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.
27 Jul 2007 - Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2.
30 Mar 2007 - Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.
30 May 1993 - Cutting edge: enhanced pulmonary clearance of Pseudomonas aeruginosa by Muc1 knockout mice.
30 Mar 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.